Genentech has a drug that if approved by the FDA will be for Progressive MS. This drug currently has Breakthrough Therapy Designation by the FDA: http://www.nationalmssociety.org/Abo...erapy-Designat
It's called Ocrelizumab. Not yet approved, but approval is likely late this year.
Check out this link: www.mssignup.com/
Genentech also has an Expanded Access Program (EAP), for patients with PPMS. An EAP allows a limited group of patients, who meet specific criteria, to have access to a specific investigational medicine.
People interested in learning more about the EAP should contact the Genentech Trial Information Support Line.
Trial Information Support Line (TISL)
(888) 662-6728
6 a.m. - 3 p.m. PST M-F
Hope this is helpful!
All The Best,
Alan
It's called Ocrelizumab. Not yet approved, but approval is likely late this year.
Check out this link: www.mssignup.com/
Genentech also has an Expanded Access Program (EAP), for patients with PPMS. An EAP allows a limited group of patients, who meet specific criteria, to have access to a specific investigational medicine.
People interested in learning more about the EAP should contact the Genentech Trial Information Support Line.
Trial Information Support Line (TISL)
(888) 662-6728
6 a.m. - 3 p.m. PST M-F
Hope this is helpful!
All The Best,
Alan
Comment